Lexeo Therapeutics Inc (NASDAQ:LXEO) price on current trading day, rose 29.67% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $2.36.
A look at the stock’s price movement, the close in the last trading session was $1.82, moving within a range at $1.75 and $2.64. Turning to its 52-week performance, $19.50 and $1.45 were the 52-week high and 52-week low respectively. Overall, LXEO moved -11.28% over the past month.
Lexeo Therapeutics Inc’s market cap currently stands at around $78.35 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Mar-23.
Turning to the stock’s technical picture we see that short term indicators suggest on average that LXEO is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
2 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 2 recommend LXEO as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
LXEO’s current price about -23.59% and -34.73% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 40.40, while 7-day volatility ratio is 34.63% and 20.33% in the 30-day chart. Further, Lexeo Therapeutics Inc (LXEO) has a beta value of 2.36, and an average true range (ATR) of 0.54. Analysts have given the company’s stock an average 52-week price target of $28, forecast between a low of $28 and high of $28. Looking at the price targets, the low is -1086.44% off current price level while to achieve the yearly target high, price needs to move -1086.44%. Nonetheless, investors will most likely welcome a -1086.44% jump to $28 which is the analysts’ median price.
If we refocus on Lexeo Therapeutics Inc (NASDAQ:LXEO), historical trading data shows that trading volumes averaged 1.4 over the past 10 days and 642.75K over the past 3 months. The company’s latest data on shares outstanding shows there are 33.07 million shares.
The 24.61% of Lexeo Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 83.16% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 2.22 million on 2025-03-14, giving us a short ratio of 4.47. The data shows that as of 2025-03-14 short interest in Lexeo Therapeutics Inc (LXEO) stood at 748.9999999999999 of shares outstanding, with shares short falling to 2.31 million registered in 2025-02-14. Current price change has pushed the stock -64.13% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the LXEO stock continues to rise going into the next quarter.
